W
Wolf H. Fridman
Researcher at University of Paris
Publications - 551
Citations - 60835
Wolf H. Fridman is an academic researcher from University of Paris. The author has contributed to research in topics: Immune system & Receptor. The author has an hindex of 97, co-authored 525 publications receiving 48713 citations. Previous affiliations of Wolf H. Fridman include Queen Elizabeth Hospital Birmingham & Pasteur Institute.
Papers
More filters
Journal ArticleDOI
Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics
Sabrina Donnou,Claire Galand,Claire Galand,Claire Galand,Cécile Daussy,Cécile Daussy,Cécile Daussy,Lucile Crozet,Lucile Crozet,Lucile Crozet,Wolf H. Fridman,Wolf H. Fridman,Wolf H. Fridman,Catherine Sautès-Fridman,Catherine Sautès-Fridman,Catherine Sautès-Fridman,Sylvain Fisson,Sylvain Fisson,Sylvain Fisson +18 more
TL;DR: It is demonstrated that the brain is able to recruit all the major actors to mount a specific anti‐tumour immune response against lymphoma, and that nude mice that received lymphoma cells intracerebrally died significantly earlier than immunocompetent animals.
Patent
Therapeutic products with enhance ability to immunomodulate cell functions
Dominique Bourel,Christophe De Romeuf,Sophie Sibéril,Wolf H. Fridman,Jean-Luc Teillaud,Nicolas Bihoreau,Emmanuel Nony +6 more
TL;DR: In this paper, a method for the production and selection of human or chimaeric or humanized antibodies or molecules that comprise the Fc region of human IgG, capable of modulating the activity of one or several particular Fc receptors, such as the triggering of inhibitory functions through the human type IIB receptors of IgG (FcgammaRIIB/CD32).
Journal Article
Fc receptors, immunoglobulin-binding factors and B chronic lymphocytic leukemia.
TL;DR: The dosage of FcRs and IBFs could bring new insights in the monitoring of B cell proliferations, including B-CLL, and the significance of these data has to be envisioned in view of the possible role of immunoglobulin-Binding Factors (IBF), FcR-related immunoregulatory lymphokines, in the control of B Cell proliferation.
Journal ArticleDOI
Immunosuppressive properties of purified immune T-interferon
Miguel A. Lucero,Juana Wietzerbin,Simon Stefanos,Claude Billardon,Ernesto Falcoff,Wolf H. Fridman +5 more
TL;DR: The kinetics of action of T-interferon on antibody synthesis show that it interferes with the early events of lymphocyte activation, and when titrated on the basis of antiviral activity no quantitative difference in the inhibition of antibody synthesis could be found.
Journal ArticleDOI
Recombinant soluble Fcγ receptors: production, purification and biological activities
Catherine Sautes,Annie Galinha,Caroline Bouchard,Noëlle Mazières,Roberto Spagnoli,Wolf H. Fridman +5 more
TL;DR: The transfection, production and purification techniques which allow the preparation of milligram amounts of glycosylated recombinant mouse and human soluble Fcγ receptors, which bind IgG and are biologically active on immune responses, like their normal counterparts are described.